Education
About Us
Working with TipRanks
Follow Us
Essex Bio-Technology Limited (HK:1061)
:1061
RESEARCH TOOLSreports
Total Valuation
Essex Bio-Technology has a market cap or net worth of HK$2.89B. The enterprise value is HK$2.36B.
Market CapHK$2.89B
Enterprise ValueHK$2.36B
Share Statistics
Essex Bio-Technology has 567,006,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding567,006,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Essex Bio-Technology’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 11.18%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)11.18%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee1.15M
Profits Per Employee211.88K
Employee Count1,450
Asset Turnover0.56
Inventory Turnover2.90
Valuation Ratios
The current PE Ratio of Essex Bio-Technology is 5.43. Essex Bio-Technology’s PEG ratio is -0.31.
PE Ratio5.43
PS Ratio0.00
PB Ratio1.39
Price to Fair Value0.79
Price to FCF24.14
Price to Operating Cash Flow6.30
PEG Ratio-0.31
Income Statement
In the last 12 months, Essex Bio-Technology had revenue of 1.67B and earned 307.22M in profits. Earnings per share was 0.54.
Revenue1.67B
Gross Profit1.50B
Operating Income320.72M
Pretax Income375.50M
Net Income307.22M
EBITDA400.71M
Earnings Per Share (EPS)0.54
Cash Flow
In the last 12 months, operating cash flow was 368.47M and capital expenditures -44.40M, giving a free cash flow of 324.07M billion.
Operating Cash Flow368.47M
Free Cash Flow324.07M
Free Cash Flow per Share0.57
Dividends & Yields
Essex Bio-Technology pays an annual dividend of HK$0.118, resulting in a dividend yield of 2.36%
Dividend Per ShareHK$0.118
Dividend Yield2.36%
Payout Ratio10.90%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.46
52-Week Price Change115.68%
50-Day Moving Average4.56
200-Day Moving Average3.14
Relative Strength Index (RSI)57.97
Average Volume (3m)2.02M
Important Dates
Essex Bio-Technology upcoming earnings date is Aug 26, 2025, TBA Not Confirmed.
Last Earnings DateMar 26, 2025
Next Earnings DateAug 26, 2025
Ex-Dividend DateMay 23, 2025
Financial Position
Essex Bio-Technology as a current ratio of 1.81, with Debt / Equity ratio of 28.29%
Current Ratio1.81
Quick Ratio1.73
Debt to Market Cap0.10
Net Debt to EBITDA-0.92
Interest Coverage Ratio52.69
Taxes
In the past 12 months, Essex Bio-Technology has paid 68.28M in taxes.
Income Tax68.28M
Effective Tax Rate0.18
Enterprise Valuation
Essex Bio-Technology EV to EBITDA ratio is 3.24, with an EV/FCF ratio of 4.01.
EV to Sales0.78
EV to EBITDA3.24
EV to Free Cash Flow4.01
EV to Operating Cash Flow3.52
Balance Sheet
Essex Bio-Technology has HK$560.74M in cash and marketable securities with HK$187.04M in debt, giving a net cash position of -HK$373.70M billion.
Cash & Marketable SecuritiesHK$560.74M
Total DebtHK$187.04M
Net Cash-HK$373.70M
Net Cash Per Share-HK$0.66
Tangible Book Value Per ShareHK$2.09
Margins
Gross margin is 90.26%, with operating margin of 19.21%, and net profit margin of 18.40%.
Gross Margin90.26%
Operating Margin19.21%
Pretax Margin22.49%
Net Profit Margin18.40%
EBITDA Margin24.00%
EBIT Margin21.25%
Analyst Forecast
The average price target for Essex Bio-Technology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-2.15%
EPS Growth Forecast12.09%